Patent Yard Sign in
Expired European patentEurope

New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof

EP 1007017 B1 · Applicant: AstraZeneca AB

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 13, 1998 and granted February 2, 2005. A European patent lasts at most 20 years from filing, so its term ended January 13, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 13, 2023.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 13, 1998
PublishedJune 14, 2000
GrantedFebruary 2, 2005
Term endedJanuary 13, 2018
Application numberEP 98901618
Classification (CPC)A61K45/06 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedJan 13, 1998PublishedJune 14, 2000Patent grantedFeb 2, 2005Term endedJan 13, 2018

Sources & verification